1ST Source Bank continued to hold its stake in CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,247 shares of the company’s stock at the end of the second quarter. 1ST Source Bank’s holdings in CME Group were worth $219,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Parametrica Management Ltd bought a new stake in CME Group during the second quarter worth about $212,000. Franklin Resources Inc. bought a new stake in CME Group during the first quarter worth about $222,000. Financial Architects Inc bought a new stake in CME Group during the second quarter worth about $234,000. EFG Asset Management Americas Corp. bought a new stake in CME Group during the first quarter worth about $244,000. Finally, Windward Capital Management Co. CA boosted its stake in CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock worth $256,000 after buying an additional 25 shares in the last quarter. 79.89% of the stock is currently owned by hedge funds and other institutional investors.
Shares of CME Group Inc. (NASDAQ:CME) traded up 0.68% during mid-day trading on Tuesday, hitting $104.44. The company had a trading volume of 253,324 shares. The firm has a 50-day moving average of $106.42 and a 200-day moving average of $99.82. The company has a market cap of $35.39 billion, a PE ratio of 26.37 and a beta of 0.83. CME Group Inc. has a 12 month low of $81.87 and a 12 month high of $110.35.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.14 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. During the same quarter in the prior year, the company posted $0.95 earnings per share. CME Group’s quarterly revenue was up 10.5% on a year-over-year basis. On average, analysts expect that CME Group Inc. will post $4.43 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date of this dividend was Wednesday, September 7th. CME Group’s dividend payout ratio is presently 60.61%.
A number of equities research analysts recently issued reports on the stock. Deutsche Bank AG lifted their price target on shares of CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a research note on Friday, July 29th. JPMorgan Chase & Co. raised their price objective on CME Group from $99.00 to $106.00 and gave the company an “overweight” rating in a report on Friday, July 29th. Barclays PLC decreased their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a report on Friday, July 29th. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a report on Thursday, June 30th. Finally, Keefe, Bruyette & Woods raised their price objective on CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a report on Friday, July 29th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $103.27.
In other CME Group news, insider Derek Sammann sold 3,550 shares of the company’s stock in a transaction on Tuesday, August 2nd. The stock was sold at an average price of $103.20, for a total value of $366,360.00. Following the sale, the insider now owns 30,896 shares of the company’s stock, valued at $3,188,467.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Phupinder Gill sold 20,080 shares of the company’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $104.54, for a total value of $2,099,163.20. Following the completion of the sale, the chief executive officer now directly owns 154,141 shares in the company, valued at approximately $16,113,900.14. The disclosure for this sale can be found here. Corporate insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.